Drug screens for regulators of the expression of the obese gene
The invention provides methods and compositions for screening for pharmacological agents which regulate satiety, fat metabolism and/or the type II diabetes mellitus in mammals, and in particular, agents active at regulating the level of ob gene expression. An exemplary assay involves (a) contacting a mammalian adipocyte comprising a mutant of a native ob allele encoding a reporter of ob gene expression, wherein the expression of the reporter is under the control of the gene expression regulatory sequences of the native ob allele, with a candidate agent under conditions whereby but for the presence of the agent, the reporter is expressed at a first expression level; and, (b) measuring the expression of the reporter to obtain a second expression level, wherein a difference between the first and second expression levels indicates that the candidate agent modulates ob gene expression. Preferred methods include cell-based transcription assays using adipocytes from transgenic animals having a &#8220;knock-in&#8221; luciferase reporter at least one ob allele.
Tularik Inc
C G C C G G G
C12N G01N C12N C12Q G01N G01N G01N
additional inventional inventional inventional inventional additional inventional
Jin-long Fabienne Charles
Chen de la Brousse